190 results
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
3 Nov 23
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
26 Sep 23
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
10 Aug 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
7 Jul 23
Entry into a Material Definitive Agreement
9:49pm
8-K
EX-10.2
SRNEQ
Sorrento Therapeutics, Inc.
7 Jul 23
Entry into a Material Definitive Agreement
9:49pm
8-K
EX-10.1
jyas29 xpbnrf5r
30 Mar 23
Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing
9:39pm
8-K
EX-10.1
40t 8sm8lxub
16 Dec 22
Departure of Directors or Certain Officers
4:10pm
425
EX-10.3
80djpeoulj vb
13 Sep 22
Business combination disclosure
6:15pm
425
EX-10.2
9pm6d
13 Sep 22
Business combination disclosure
6:15pm
425
EX-10.1
40njy6qo
13 Sep 22
Business combination disclosure
6:15pm
8-K
EX-10.1
9adrn2hk2
13 Sep 22
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.3
yg1zdcz4oyevn9rjgc8x
13 Sep 22
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.2
u94bk0 1jpnv
13 Sep 22
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.1
7dhr2wddg1 g6wsiri
3 Jun 22
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured Notes
9:00am
8-K
EX-10.2
nd5yi rryd8x
28 Apr 22
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.1
5jckn5cttt
28 Apr 22
Departure of Directors or Certain Officers
9:00am
425
EX-10.2
5qrekyl
18 Mar 22
Business combination disclosure
9:03am